论文部分内容阅读
直至近几年以前,卡波济氏肉瘤(KS)在北美和欧洲还是罕见的,而在中非却是普遍存在,特别影响老年人并呈顽同性病程,许多人可存活十午或更久。在儿童中及接受肾移植者中偶可见到病例,但病情严重,病变可波及全身器官。自1981年以来,在AIDS病人中KS数量增多,临床上早期症状与儿童期KS相同。由于可从许多AIDS病人身上分离到病毒及AIDS危险人群中具有特异性抗体的优势,而把人类嗜T淋巴
Until recently, Kaposi’s sarcoma (KS) was rare in North America and Europe, but widespread in Central Africa, affecting the elderly in particular and having a co-morbid course of disease, many surviving for ten or more years . Occasionally seen in children and kidney transplant recipients, but the condition is serious, the disease can affect the whole body organs. Since 1981, there has been an increase in the number of KS in AIDS patients, and the clinical symptoms are similar to childhood KS. Due to the advantages of having specific antibodies isolated from many AIDS patients and those at risk of AIDS, human T-lymphomas